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Adaptive immunityNuclear receptors are a family of ligand regulated factors that exert homeostatic functions at the interface
between metabolic and immune function. The farnesoid X receptor (FXR) is a bile acid sensor expressed
in immune cells such as macrophages where it exerts counter-regulatory effects. FXR deﬁcient mice
demonstrate disregulated immune response. Expression of FXR is down-regulated in inﬂamed tissues but
the mechanism that leads to FXR down-regulation by inﬂammatory mediators is unknown. In the
present study we have investigated the effect of inﬂammation-related cytokines on macrophages and
demonstrated that INFγ is a potent inhibitor of FXR gene expression/function in macrophages. STAT1
silencing and over-expression experiments demonstrated that FXR repression is mediated by INFγ
dependent activation of STAT1. Since IFNγ is a potent activator of STAT1 we searched for STAT1 binding
sites in the human FXR genomic and identiﬁed a region of the human FXR gene between the second and
third exon that contains three hypothetical STAT1 binding sites. RAW 264.7 transiently transfected with
an FXR genomic reporter construct which contained the three STAT binding sites responded to IFNγ with
a robust decrease in the reporter activity, demonstrating the potent modulation of FXR transcription by
IFNγ. Chromatin immunoprecipitation assay revealed that this region was immunoprecipitated following
treatment of macrophage cell lines and supershift assay demonstrated that STAT1 was able to bind one
of three identiﬁed sites. In summary, these results suggest that IFNγ induced STAT1 homodimers
modulate the transcriptional repression of FXR gene in macrophages during inﬂammation-related
cytokines.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Metabolic nuclear receptor are a family of ligand-activated
transcription factors that share a common structure characterized
by a highly conserved DNA-binding domain that recognizes speciﬁc
DNA sequences connected via a linker region to a C-terminal
ligand-binding domain [1–3]. In addition to their role in metabo-
lism regulation, several members of this family exert counter-
regulatory effects on key aspects of the immune system [4,5]. Thus
in addition to the glucocorticoid receptor, also the peroxisome
proliferator-activated receptors (PPARs), the estrogen receptor β,
liver-X-receptor α and β (LXR), vitamin D receptor, constitutive
andronstane receptor and pregnane X receptor, play a role in
maintaining immune system homeostasis [6]. Deletion of these
genes, often results in an un-regulated immune response and a
pro-inﬂammatory phenotype [7]. A reciprocal regulation existsand Experimental Medicine,
ly. Tel./Fax: +39 0755857205.
ll rights reserved.between these receptors and inﬂammatory genes. For example,
PPARγ activation counter-regulates inﬂammation and inhibits the
production of tumor necrosis factor (TNF)-α, but its expression is
greatly reduced in inﬂamed tissues in response to local cytokine
production, suggesting that repression of metabolic nuclear
receptors might be a mechanism required for inﬂammation to
progress [1,2,8–11].
The farnesoid X receptor (FXR) is a member of the nuclear receptor
superfamily of ligand-activated transcription factors primarily
expressed in entero-hepatic tissues [3–5]. FXR functions as an
endogenous sensor for bile acids, being the primary bile acid,
chenodeoxycholic acid (CDCA), the most potent of its endogenous
ligands and regulates cholesterol, fatty acid and glucose metabolism
[12–17]. In its active conﬁguration FXR forms a heterodimer with the
retinoid X receptor (RXR). The FXR/RXR heterodimer binds to two
AGGTCA half sites separated by one nucleotide, inverted repeat (IR-1),
on target genes [3–5]. FXR interferes with the activities of transcrip-
tion factors that activate inﬂammatory pathways through a mechan-
ism that involves protein–protein interactions with nuclear factor κB
(NF-κB) and activator protein 1 (AP-1) (trans-repression) [18,19].
Several mediators regulate FXR expression. The liver enriched
Fig. 1. FXR expression in macrophages. Panel A. Qualitative PCR showing the expression
of FXR mRNA in macrophages cell lines RAW264.7 and THP-1. HEPG2 is the positive
control in this experiment. Panel B.Western blotting anti FXR showing the expression of
FXR protein in macrophages cell lines RAW264.7 and THP-1. HEPG2 is the positive
control in this experiment. Panel C. Qualitative PCRWestern blot analysis of FXR mRNA
expression by PMBC-derived CD14+ and HepG2 cells. Panel D. Western blot analysis of
FXR protein expression by PMBC-derived CD14+ and HepG2 cells.
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high density lipoprotein (HDL)-cholesterol metabolism, is a potent
activator of FXR gene expression in the liver [20]. In contrast, glucose,
insulin, activation of toll like receptor (TLR)-4 and endotoxin-
regulated cytokines, such as TNF-α and interleukin (IL)-1β, negatively
regulate FXR expression in various tissues [17,21].
The Signal Transducers and Activator of Transcription (STAT)
proteins are a family of seven regulatory proteins (1, 2, 3, 4, 5A and 5B
and STAT6) that play a role in immune tolerance and tumor
surveillance [22]. The ﬁrst two STAT proteins were identiﬁed in the
interferon (IFN) system and STAT1 homodimers mediates type II IFN
signalling. Janus activated kinase (JAK) is a non-receptor tyrosine
kinase which activates STATs [23].
When IFNγ binds to its receptor on the plasma membrane, JAK
phoshorylates the tyrosine 701 residue of STAT1 [23,24]. Following
tyrosine phosphorylation, the SH2 domain of one STAT1 monomer
recognizes the phosphorylated tyrosine residue of the other STAT1
monomer and generates the STAT1 homodimer [22,23]. This
homodimerization induces the nuclear localization of STAT1, an
event that is followed by its binding to the promoter regions of
genes containing gamma activated site (GAS) motif, causing the
transcription or repression of these genes [22,23,24]. Previous
studies have shown that exposure of 3T3-L1 adipocytes to IFNγ
results in STAT1-dependent repression of PPARγ transcription and
that the PPARγ2 promoter contains a highly speciﬁc STAT1 binding
site [25].
Because the mechanisms that regulate FXR transcription are
largely unknown we have investigated whether IFNγ regulates FXR
gene expression and activity and whether this effect involves STAT1
activation. The results of these experiments support the notion that a
reciprocal regulation exists between the bile acid sensor FXR and IFNγ
regulated pathways in macrophages. This mechanism might play a
major role in regulating innate immune response to nutrients and
cholesterol-derived mediators.
2. Materials and methods
2.1. Cell culture
RAW264.7 were grown at 37 °C in D-MEM containing 10% FBS, 1%
L-glutamine and 1% penicillin/streptomycin. THP-1 were grown at
37 °C in RPMI containing 10% FBS, 1% L-glutamine and 1% penicillin/
streptomycin. HEPG2 were grown at 37 °C in E-MEM containing 10%
FBS, 1% L-glutamine and 1% penicillin/streptomycin. Cells were
regularly passaged to maintain exponential growth. Human periph-
eral blood derived mononuclear cells (PBMCs) were obtained from
normal individual donors to the Blood Bank Service of Perugia
University Hospital. PBMCs were isolated by density gradient
centrifugation through a Ficoll-Hypaque gradient (Pharmacia Biotech
AB, Uppsala, Sweden). Monocytes, were isolated by negative selection
usingmagnetic cell sorting according to themanufacturer instructions
(Mylteni Biotec, Milan, Italy). Assessment of FXR expression on
puriﬁed monocytes was carried out by qualitative PCR and Western
blot analysis.
2.2. Western blotting
Total lysates were prepared by solubilization of cells in NuPage
sample buffer (Invitrogen) containing Sample reducing agent
(Invitrogen) and separated by polyacrylamide gel electrophoresis
(PAGE). The proteins were then transferred to nitrocellulose
membranes (Bio-Rad) and probed with primary antibodies FXR
(Santa Cruz, H-130), phosphoSTAT1(Tyr701) (Cell Signaling), STAT1
(Cell Signaling) or Tubulin (Sigma). The anti-immunoglobulin G
horseradish peroxidase conjugate (Bio-Rad) was used as the
secondary antibody, and speciﬁc protein bands were visualizedusing Super Signal West Dura (Pierce), following the manufacturer's
suggested protocol.
2.3. RNA extraction
Total RNA was isolated from cells using the TRIzol reagent
according to the manufacturer's speciﬁcations (Invitrogen, Milan,
Italy). One microgram RNA was puriﬁed of the genomic DNA by
DNase-I treatment (Invitrogen) and random reverse-transcribed with
Superscript II (Invitrogen) in 20 μl reaction volume.
2.4. Qualitative and quantitative PCR
For qualitative and quantitative PCR conditions were as previously
described [26]. All PCR primers were designed using software
PRIMER3-OUTPUT using published sequence data from the NCBI
database. Quantiﬁcation of gene expression was performed using the
following sense and antisense primers: mGAPDH: ctgagtatgtcgtg-
gagtctac and gttggtggtgcaggatgcattg; mFXR: tgtgagggctgcaaaggttt
and acatccccatctctctgcac; mTNFα: acggcatggatctcaaagac and
gtgggtgaggagcacgtagt; mIL1β: tcacagcagcacatcaacaa and
tgtcctcatcctcgaaggtc; mIFNγ: gctttgcagctcttcctcat and gtcac-
catccttttgccagt; mIRF1: gcaaaaccaagaggaagctg and gagactgctgctgac-
gacac; mMCP1: cccaatgagtaggctggaga and tctggacccattccttcttg;
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gggaatgtcaccaggaatgt and tgagttttatggcctcctcct;mSTAT1: cttgacgaccc-
taagcgaac and ccgggacatctcatcaaact; hGAPDH: gaaggtgaaggtcggagt
and catgggtggaatcatattggaa; hFXR: tacatgcgaagaaagtgtcaaga and
actgtcttcattcacggtctgat; hSTAT-RE (used for ChIP experiment):
catgaccaaggtagatcatgac and cccaagatacgtgcttgcat.
2.5. Construction of reporter plasmids
The genomic DNA fragment containing the HindIII site, the
HNF1α response element, the STATP1, STATP2 and STATP3 putative
binding sites was synthesized at MWG-Euroﬁns. The following
sense and antisense primers were then oligo annealed and
phosphorylated at 5′: HindIII-HNF1αRE-STATREs sense, 5′-AAGCT-
TATTGTTAATGACTAATCTGTTTTCCTCTAAATTTCTAATAAATTTCAGA-
TAAA-3′; HindIII-HNF1αRE-STATREs antisense, 5′-TTTATCTGAAA
TTTATTAGAAATTTAGAGGAAAACAGATTAGTCATTAACAA-
TAAGCTT-3′. After 3′ dATP attachment using Taq DNA Polymerase
(Invitrogen), double strand oligo was cloned into pCR.2.1 by using
TOPO TA cloning kit (Invitrogen). From pCR2.1 vector, the genomic
fragment was extracted and then subcloned into pGL3 basic vector
using the restriction enzymes Kpn-I and Xho-I (pGL3HNF1αRE/
STAT1REs). The same cloning strategy was used for the cloning of the
STATP2 mutated binding site into pGL3 vector (pGL3HNF1αRE/
STAT1ResP2mut) by using the following sense and antisense primers:
HindIII-HNF1αRE-STATREs-P2mut sense, 5′-AAGCTTATTGTTAATGAC-
TAATCTGTTTTCCTCTAAATGTATCGTACATTTCAGATAAA-3′; HindIII-
HNF1αRE-STATREs-P2mut antisense, 5′-TTTATCTGAAATGTACGATA-
CATTTAGAGGAAAACAGATTAGTCATTAACAATAAGCTT-3′.Fig. 2. FXR activation regulates macrophage activation induced by IFNγ. Panel A, B, C and D.
absence of 6ECDCA 1 μM for 18 h. Quantitative RT-PCR showing themodulation of IRF1, IP10,
°pb0.05 versus IFNγ treated cells).2.6. Transactivation assay
All transfection experiments carried out using Fugene HD
according to manufacturer speciﬁcations (Roche). RAW264.7 cells
were transfected with 1 μg of pGL3 or 1 μg of FXR genomic
luciferase reporter vector containing the HNF1α and STAT respon-
sive elements (pGL3HNF1αRE/STAT1REs) or 1 μg of FXR genomic
luciferase reporter vector containing the HNF1α and STAT respon-
sive elements containing the mutated STAT-P2 binding site
(pGL3HNF1αRE/STAT1ResP2mut), with 200 ng pCMV-βgal, as inter-
nal control for transfection efﬁciency, with 100 ng of pSG5-HNF1α
or 100 ng of pSG5-STAT1 or with the combination of pSG5-HNF1α
and pSG5-STAT1. The pGEM vector was added to normalize the
amounts of DNA transfected in each assay (2.5 μg/well). Forty-eight
hours post-transfection, cells were stimulated with 100 ng/ml INFγ
for 18 h. Control cultures received vehicle (0.1% DMSO) alone. Cells
were lysed in 100 μl diluted reporter lysis buffer (Promega), and 5 μl
cellular lysates were assayed for luciferase activity using Luciferase
Assay System (Promega) and luminescence measured by an
automated luminometer. Luciferase activities were normalized for
transfection efﬁciencies by dividing the relative light units by β-
galactosidase activity. All experiments were done in triplicate and
were repeated at least once.
2.7. Electrophoretic mobility shift assay (EMSA)
Preparation of nuclear extract from THP-1 cells not treated or
stimulated with INFγ at 100 ng/ml for 18 h were done using NE-
PER (PIERCE). The probes used for electrophoretic mobility shiftRAW264.7 cells serum starved were stimulated with IFNγ 100 ng/ml in presence or in
MCP1 and ICAM1mRNA expression by 6E-CDCA. n=4; ⁎pb0.05 versus not treated cells,
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labeling kit (PIERCE) according to the manufacturer's instructions.
The sequences of probes used were: P1: TTTCCTCTAAA; P2:
TTTCTAATAAA and P3: TTTCAGATAAA. For EMSA, 5 μg of nuclear
extract were incubated with 15 fmol of the indicated biotin-end-
labeled probes in a total volume of 20 μl of binding buffer (50 mM
NaCl, 10 mM Tris–HCl, pH 7.9, 0.5 mM EDTA, 10% glycerol, 1 μg of
poly dI–dC) for 20 min at room temperature. For competition
assays, excess unlabeled oligonucleotides were preincubated with
nuclear extract for 15 min prior to the addition of the biotin-labeled
probe. The reactions were loaded on a 6% polyacrylamide non-
denaturing gel in 0.5× Tris–borate–EDTA and electrophoresed for
1 h at 100 V. The protein/DNA complexes were then transferred to
positively charged nylon membrane (PIERCE) and the supershift was
detected using Chemiluminescent Nucleic Acid Detection Module
(PIERCE).
2.8. Chromatin immunoprecipitation (ChIP)
A ChIP assay was performed according to the manufacturer's
protocols (Abcam Ltd, Cambridge, UK) with minor modiﬁcations. In
brief, THP1 cells not treated or stimulated with INFγ at 100 ng/ml
for 18 h were cross-linked with 1% formaldehyde at room
temperature and the reaction was terminated by the addition of
glycine to a ﬁnal concentration of 0.125 M. Cells were washed in ice-
cold PBS and lysed with SDS lysis buffer (1% SDS, 10 mM EDTA, and
50 mM Tris–HCl, pH 8). Cellular lysates were diluted with ChIP
dilution buffer, sonicated, and immunoprecipitated with speciﬁcFig. 3. FXR over-expression modulates the IFNγ induced target genes. Panel A. Quantitative
FXR. (n=3; ⁎pb0.05 versus not transfected cells). Panels B, C, D and E. RAW264.7 cells
Quantitative RT-PCR showing themodulation of IRF1, IP10, MCP1 and ICAM1mRNA expressio
stimulated with IFNγ and over-expressing FXR).antibody: anti-STAT1 or anti-phosphoSTAT1(Tyr701) from Cell
Signaling. Immunoprecipitates were collected with protein A beads
(Amersham Bioscience) and washed sequentially ﬁrst with a low-
salt wash buffer and then with high-salt wash buffer using
manufacturer's recommended procedures. DNA was eluted by
addition of 1% SDS and 0.1 M NaHCO3, and the cross-linking
reactions were reversed by heating the mixture to 65 °C overnight.
The DNA was recovered from immunoprecipitated material by
proteinase K treatment at 65 °C for 1 h followed by phenol/
chloroform (1:1) extraction, ethanol precipitation and dissolved into
50 μl of water. Five microliters of the extract was used for
quantitative real-time PCR (qRT-PCR).
2.9. Transient transfection of STAT1 and HNF1α constructs
All the transfections were making using Fugene HD according to
manufacturer speciﬁcations (Roche). 2×106 RAW264.7 cells were
transfected with 5 μg of expression vector pCMVHNF1α alone or in
combination with 5 μg of expression vector pCMVSTAT1 or 5 μg of
silencing vector psiRNASTAT1 (Origene). Forty-eight hours post-
transfection, cells were stimulated with 100 ng/ml INFγ for 18 h.
Control cultures received vehicle (0.1% DMSO) alone. Cells were lysed
in Tryzol and RNA was extracted as above.
2.10. Statistical analysis
All values are expressed as mean±SE of n observations per group.
Comparisons of more than two groups were made with a one-wayRT-PCR showing the FXR over-expression in RAW264.7 transfected with pCMVSPORT6-
over-expressing FXR, serum starved, were stimulated with IFNγ 100 ng/ml for 18 h.
n following FXR over-expression. (n=4; ⁎pb0.05 cells stimulatedwith IFNγ versus cells
Fig. 4. FXR over-expression and its activation by 6-ECDCA resulted in an almost complete abrogation of the stimulatory effect exerted by IFNγ. RAW264.7 cells were transiently
transfected with pCMVSPORT6-FXR, serum starved 18 h and then stimulated with IFNγ 100 ng/ml in presence or in absence of 6ECDCA 1 μM for 18 h. Quantitative RT-PCR showing
the almost complete down-regulation of IRF1 (Panel A), IP10 (Panel B), MCP1 (Panel C) and ICAM1 (Panel D) mRNA expression following FXR over-expression and activation by
6ECDCA. (n=4; ⁎pb0.05 versus not treated cells, #pb0.05 versus IFNγ stimulated cells).
Fig. 5. IFNγ modulates FXR expression. Panel A. Quantitative RT-PCR showing the
reduction of FXR mRNA in macrophages RAW264.7 serum starved and stimulated with
IFNγ 100 ng/ml 18 h. (n=3; ⁎pb0.05 versus not treated cells). Panel B. Western
blotting anti FXR showing FXR protein down-regulation in RAW 264.7 serum starved
and stimulated with IFNγ 100 ng/ml for 24, 48 and 72 h.
568 B. Renga et al. / Biochimica et Biophysica Acta 1792 (2009) 564–573ANOVA with post-hoc Tukey's test. Differences were considered
statistically signiﬁcant if p was b0.05.
3. Results
3.1. FXR is expressed in macrophages and regulates macrophages
activation induced by IFNγ
We have ﬁrst examined whether macrophage cell lines and
peripheral blood derived mononuclear cells (PBMCs) express FXR.
HepG2, a hepatocarcinoma cell line expressing high levels of FXR
mRNA, was used as a positive control. Expression of FXR mRNA was
detected by qualitative PCR in both human (THP1) and mouse
(RAW264.7) macrophage cells lines (Fig. 1A). FXR protein
(≈55 kDa) was detected by Western blot analysis in HepG2 cell
line (positive control) and, thought to a lower level, in RAW264.7
and THP1 cells lines (Fig. 1B). In addition, FXR expression was
detected by qualitative RT-PCR and Western blot analysis in PBMCs
(Fig. 1C and D).
To investigate whether FXR acts as a regulatory gene in the context
of macrophages activation induced by IFNγ (100 ng/ml for 18 h),
RAW264.7 cells were exposed to 6E-CDCA 1 μM, a semi-synthetic bile
acid derivative that activates FXR with an EC50 of ∼300 nM (being the
EC50 of CDCA, the most potent of naturally occurring bile acid ligands,
∼10 μM). As shown in Fig. 2, FXR activation with 6-ECDCA, caused a
signiﬁcant down-regulation of the expression of several IFNγ-
responsive genes, including MCP-1 and ICAM-1 (n=4; ⁎pb0.05
versus not treated cells, °pb0.05 versus IFNγ treated cells). Because
cultured macrophages express low levels of endogenous FXR, we have
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robust regulation of IFNγ activity. For this purpose RAW264.7 were
transiently transfected with pCMVSPORT6-FXR, serum starved 18 h,
and then stimulated with IFNγ (100 ng/ml for 18 h). Over expression
of FXR was conﬁrmed by RT-PCR (Fig. 3A, n=3; ⁎pb0.05 versus not
transfected cells). FXR over-expressionwas sufﬁcient to cause a robust
inhibition of the expression of IFNγ regulated genes (Fig. 3B, C, D and E
n=4; ⁎pb0.05 cells stimulated with IFNγ versus cells stimulated with
IFNγ and over-expressing FXR). This effect was further enhanced by
exposure to 6-ECDCA at 1 μM. Thus, the combination of FXR over-
expression and its activation by 6-ECDCA resulted in an almost
complete abrogation of the stimulatory effect exerted by IFNγ on IRF1,Fig. 6. Panel A. Western blotting analysis of STAT1 and phospho-STAT1(Tyr701) proteins foll
PCR showing STAT1 over-expression in RAW264.7 cells transfected with pCMVSTAT1 (n=
expression in RAW264.7 cells transfected with pCMVSTAT1 and pCMVHNF1α (n=4; #pb0.0
relative expression in RAW264.7 cells transfected with pCMVHNF1α (white bars) or with bo
(n=4; ⁎pb0.05 versus not treated HNF1α alone expressing cells, n=4; #pb0.05 versus no
silencing in RAW264.7 cells transfected with psiRNASTAT1. (n=4; ⁎pb0.05 versus not tran
transfected with psiRNASTAT1 and pCMVHNF1α. (n=4; ⁎pb0.05 versus not transfected cells
mRNA relative expression in RAW264.7 cells transfected with pCMVHNF1α (white bars) or w
for 18 h. (n=4; ⁎pb0.05 versus not treated HNF1α alone expressing cells).IP10, MCP1 and ICAM-1 (Fig. 4A, B, C and D n=4; ⁎pb0.05 versus not
treated cells, #pb0.05 versus IFNγ stimulated cells).
3.2. IFNγ treatment results in a decrease of FXR expression
Because FXR seems to act as an endogenous counter-regulatory
gene, one would speculate that macrophages activation should
regulate its expression in order to allow the progression of an
immune response. As shown in Fig. 5A exposure to IFNγ (100 ng/ml),
results in a signiﬁcant decrease of FXR expression as assessed by RT-
PCR (Fig. 5A, n=3; ⁎pb0.05 versus not treated cells) and Western
blot analysis (Fig. 5B).owing IFNγ treatment of RAW264.7 for 5–15–30–60 and 180 min. Panel B. Quantitative
4; ⁎pb0.05 versus not transfected cells) Panel C. Quantitative PCR showing STAT1
5 versus HNF1α alone expressing cells). Panel D. Quantitative PCR showing FXR mRNA
th pCMVSTAT1 and pCMVHNF1α (black bars) stimulated with IFNγ 100 ng/ml for 18 h.
t treated HNF1α and STAT1 expressing cells). Panel E. Quantitative PCR showing STAT1
sfected cells). Panel F. Quantitative PCR showing STAT1 expression in RAW264.7 cells
; #pb0.05 versus HNF1α alone expressing cells). Panel G. Quantitative PCR showing FXR
ith both psiRNASTAT1 and pCMVHNF1α (black bars) stimulated with IFNγ 100 ng/ml
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Since STAT1 is a critical mediator in the propagation of IFNγ-
mediated signals in macrophages, we have examined whether
exposure of RAW264.7 cells to IFNγ 100 ng/ml causes STAT1
phosphorylation on Tyrosine 701. As shown in Fig. 6A an increase in
STAT1 phosphorylation was observed between 30′ and 180′ after
treatment with IFNγ, while Western blotting analysis of total STAT1
protein failed to show any increase in total protein level.
To investigate whether STAT1 mediates the FXR transcriptional
repression induced by IFNγ, RAW264.7 cells were co-transfected with
plasmids containing a coding sequence for HNF1α and STAT1
(pCMVHNF1α and pCMVSTAT1) and than stimulated with IFNγ,
100 ng/ml, for 18 h. pCMVHNF1α was used as a positive regulator to
induce the FXR transcription in these cells. Quantitative RT-PCR
demonstrated that the relative expression of STAT1 in RAW264.7 cells
transfected with pCMVSTAT1 was signiﬁcantly enhanced in compar-
ison with RAW264.7 cells not transfected or transfected with
pCMVHNF1α only (Fig. 6B and C, n=4; ⁎pb0.05 versus not
transfected cells; #pb0.05 versus HNF1α alone expressing cells).
FXR mRNA expression in RAW264.7 over-expressing HNF1α and
STAT1 was reduced by 50% in comparison to cells transfected with
pCMVHNF1α only (Fig. 6D, columns 1 and 2; n=4; ⁎pb0.05 versus
not treated HNF1α alone expressing cells). In addition, the FXR mRNA
expression was further down-regulated by treating STAT1 over-
expressing RAW264.7 cells with IFNγ (Fig. 6D, columns 3 and 4
n=4; ⁎pb0.05 versus not treated HNF1α alone expressing cells,
n=4; #pb0.05 versus not treated HNF1α and STAT1 expressing cells).
To further investigate the role of STAT1 in regulating FXR gene
expression, STAT1 mRNA expression in RAW264.7 was silenced using
a commercial plasmid containing a siRNA for STAT1 (psiRNASTAT1;
Origene). As shown in Fig. 6E transfection of STAT1 siRNA attenuated
STAT1 mRNA expression by 50% in comparison to cells not transfectedFig. 7. Panel A. Analysis of the human FXR gene, showing three putative STAT1 binding site
HNF1α responsive element and STAT1 putative binding sites (pGL3HNF1αRE/STAT1REs). Pa
pGL3HNF1αRE/STAT1REs), with luciferase vector plus HNF1α expression vector (black b
pCMVSTAT1), or with luciferase vector and both HNF1α and STAT1 expression vectors (stripe
IFNγ 100 ng/ml for 18 h. Luciferase activity is show as the ratio of luciferase to β-galac
pGL3HNF1αRE/STAT1REs alone trasfected cells; °pb0.05 versus pCMVHNF1α expressing ceor transfected with pCMVHNF1α alone (Fig. 6E and F, n=4; ⁎pb0.05
versus not transfected cells #pb0.05 versus HNF1α alone expressing
cells). To investigate whether STAT1 abrogation interfere with the
ability of IFNγ to modulate the expression of FXR, STAT1-deﬁcient
RAW264.7 were co-transfected with a plasmid containing the coding
sequence for HNF1α (pCMVHNF1α and psiRNASTAT1). While
exposure of RAW264.7 transfected with the pCMVHNF1α to IFNγ
(100 ng/ml for 18 h) resulted in a robust down-regulation of FXR
mRNA expression, this inhibitory effect was completely abrogated by
STAT1 silencing (Fig. 6G, n=4; ⁎pb0.05 versus not treated HNF1α
alone expressing cells).
3.4. IFNγ modulates the transcription of the FXR gene
We have then examined whether FXR genomic sequences
contains responsive elements for IFNγ. We focused our search on
GAS like elements (consensus GAS sequence: TTTCNNNNAAA) [25]
that are known to mediate IFNγ sensitive genes in a STAT1
dependent manner. Our analysis revealed that a region in the
human FXR genomic between the second and the third exon
contains three putative STAT1 response elements (Fig. 7A). To
determine if this region of the human FXR genomic was sensitive to
IFNγ regulation we generated a luciferase reporter construct
(pGL3HNF1αRE/STAT1REs) which contains the HNF1α responsive
element cloned from the human FXR 5′ ﬂanking region and the
region containing the three putative STAT1 responsive elements
(Fig. 7B). This vector was then transiently transfected into
RAW264.7 cells. In each experiment cells were co-transfected with
a β-galactosidase vector as a control for the transfection efﬁciency.
In addition, RAW 264.7 were also co-transfected with HNF1α
expression vector (pCMVHNF1α) alone or in combination with
STAT1 expression vector (pCMVSTAT1). As expected co-transfection
of pGL3HNF1αRE/STAT1REs with HNF1α expression vector resulteds between second and third exon. Panel B. Luciferase reporter vector containing both
nel C. RAW264.7 cells were trasfected with luciferase reporter vector alone (white bars:
ars: pCMVHNF1α), with luciferase vector plus STAT1 expression vector (grey bars:
d bars: pHCMVNF1α+pCMVSTAT1). 24 h post-transfection cells were stimulated with
tosidase activities. Data represent the mean±S.D. of 3 experiments. ⁎pb0.05 versus
lls; #pb0.05 versus not stimulated cells.
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tion of the luciferase reporter construct alone (Fig. 7C, columns 1
and 3, n=3, ⁎pb0.05 versus pGL3HNF1αRE/STAT1REs alone
trasfected cells). Co-transfection of pGL3HNF1αRE/STAT1REs with
STAT1 expression vector alone resulted in a greater down-regulation
of luciferase activity compared to transfection of pGL3HNF1αRE/
STAT1REs alone (Fig. 7C, columns 1 and 5, n=3 ⁎pb0.05 versus
pGL3HNF1αRE/STAT1REs alone trasfected cells). Co-transfection
with both HNF1α and STAT1 expression vectors decreased luciferase
activity in comparison with pCMVHNF1α alone transfected cells
(Fig. 7C, columns 3 and 7, °pb0.05 versus pCMVHNF1α expressing
cells). The treatment of all transfected cells with IFNγ (100 ng/ml
for 18hours), resulted in a robust reduction of luciferase activity
compared to not stimulated cells (Fig. 7C, lanes 2,4,6 and 8, #pb0.05
versus not stimulated cells). These results suggest that modulationFig 8. Panel A. STAT1 binds to FXR genomic in the context of chromatin structure. ChIP experim
ml for 18 h. Chromatin was prepared, immunoprecipitated with antibodies directed against S
genomic between second and third exonwas performed. Data represent themean±S.D. of 4
#pb0.05 versus not treated cells immunoprecipitated with phosphoSTAT1 antibody. Pane
performed using three different probes designed P1, P2 and P3. Each probe matches a sing
extracts from THP1 not treated or treated with IFNγ 100 ng/ml for 18 h. Competition experim
biotin labeled was not incubated or incubated with nuclear extracts from THP1 cells not trea
were performed using a 50 fold excess of unlabeled oligo or 1 μg of STAT1 antibody (lanes 4 a
with nuclear extracts from THP1 stimulated cells (lanes 6 and 7). Panel D. Mutated STAT
RAW264.7 cells were transfected with the luciferase reporter vector pGL3HNF1αRE/S
pCMVSTAT1expression vectors (black bars), with luciferase reporter vector pGL3HNF1αR
pCMVHNF1α and pCMVSTAT1 expression vectors (striped bars). 24 h post-transfection cells
luciferase to β-galactosidase activities. Data represent the mean±S.D. of 3 experiment
pGL3HNF1αRE/STAT1REs, pCMVHNF1α and pCMVSTAT1 transfected cells not stimulated wof FXR transcription by IFNγ could be mediated by a region of FXR
genomic between the second and third exon containing putative
STAT1 binding sites.
3.5. STAT1 binds to the FXR regulatory region in vitro
To investigate the interaction between STAT1 and FXR genomic,
chromatin immunoprecipitation (ChIP) was performed using serum
starved THP1 cells exposed to INFγ (100 ng/ml for 18 h). As shown in
Fig. 8A, quantitative real-time PCR of the FXR genomic between the
second and third exon conﬁrmed the binding of both the proteins
STAT1 and STAT1 phosphorylated on the FXR genomic (Fig. 8A, n=4;
⁎pb0.05 versus not treated cells immunoprecipitated with STAT1anti-
body, #pb0.05 versus not treated cells immunoprecipitated with
phosphoSTAT1 antibody).ents were performed in THP1 serum starved not treated and treated with IFNγ 100 ng/
TAT1 and phospho-STAT1 (Tyr 701) proteins and quantitative real-time PCR of the FXR
experiments. ⁎pb0.05 versus not treated cells immunoprecipitatedwith STAT1antibody,
l B. STAT1 binds to FXR genomic in vitro. Electrophoretic mobility shift assays were
le GAS like response element. Probes were biotin labeled and incubated with nuclear
ents were performed using a 50 fold excess of unlabeled oligo. Panel C. STAT1 P2 probe
ted or treated with IFNγ 100 ng/ml for 18 h (lanes 1,2 and 3). Competition experiments
nd 5). Mutated P2 probe and positive control STAT1 probe biotin labeled were incubated
1 response element P2 failed to reduce the transactivation following IFNγ treatment.
TAT1REs alone (white bar), with pGL3HNF1αRE/STAT1REs plus pCMVHNF1α and
E/STAT1ResP2mut alone (grey bar), or with pGL3HNF1αRE/STAT1ResP2mut and both
were stimulated with IFNγ 100 ng/ml for 18 h. Luciferase activity is show as the ratio of
s. ⁎pb0.05 versus pGL3HNF1αRE/STAT1REs alone trasfected cells; #pb0.05 versus
ith IFNγ; °pb0.05 versus pGL3HNF1αRE/STAT1ResP2mut alone transfected cells.
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the human FXR genomic region between the second and third exon
binds STAT1 we performed an EMSA using three different probes
designed P1, P2 and P3. Each probematches a single GAS like response
element. These probes were biotin labeled and incubated with nuclear
extracts prepared from THP1 cells untreated or treated with INFγ
100 ng/ml for 18 h. As shown in Fig. 8B, while the ﬁrst putative STAT1
response element, P1, failed to bind nuclear extracts from THP1
treated with IFNγ, a robust binding was observed with the second
probe, P2. Finally, the third probe, P3, was also able to bind nuclear
extracts from THP1 both in the absence and in presence of IFNγ
indicating that the binding of probe P3 to the FXR genomic is
indipendent to IFNγ activation. DNA binding and supershift was
almost completely abrogated using a mutated STAT1 P2 probe as well
as an anti STAT1 antibody, while when STAT1 binding probe (IRF1-
GAS: TTTCCCCGAAA) was used as positive control we observed the
same supershift of the probe P2 (Fig. 8C lanes 5, 6 and 7). Finally, to
conﬁrm that only the P2 STAT1 binding site is necessary to down-
regulate FXR gene expression, we performed a luciferase experiment
with a vector containing a mutation of the P2 site (pGL3HNF1αRE/
STAT1ResP2mut). As shown in Fig. 8D, the mutation of P2 binding site
failed to down-regulate the FXR transcription in presence of INFγ
treatment (Fig. 8D, n=3; ⁎pb0.05 versus pGL3HNF1αRE/STAT1REs
alone transfected cells; #pb0.05 versus pGL3HNF1αRE/STAT1REs,
pCMVHNF1α and pCMVSTAT1 transfected cells not stimulated with
IFNγ; °pb0.05 versus pGL3HNF1αRE/STAT1ResP2mut alone trans-
fected cells).
All together, these results suggest that modulation of FXR
transcription by IFNγwasmediated only by the STAT1 binding site P2.
4. Discussion
Inﬂammatory host responses to foreign challenge involve a
complex network of mediators that establish both an innate and
acquired immune response. Although beneﬁcial in the setting of
defence of the host against infectious invaders, this network of
immune mediators can become unchecked, contributing to the
pathogenesis of common chronic inﬂammatory diseases such as
atherosclerosis [27], obesity-induced insulin resistance[28], arthritis
[29], inﬂammatory bowel disease [30] and multiple sclerosis [31]. At
its basic cellular level, many of the signalling mediators that are
produced by these chronic inﬂammatory events are under the
transcriptional control of early transcription factors including NF-kB
and AP-1 [32,33].
Recent attention has been directed at several members of the
nuclear receptor superfamily because of their physiological roles as
negative regulators of inﬂammatory responses [34,35]. For example
glucocorticoid receptor (GR), the prototypical receptor of this class of
agents, senses endogenous steroids generated by cholesterol meta-
bolism and inhibits inﬂammation. GR-mediated inhibition of inﬂam-
mation involves the trans-repression of inﬂammatory mediators
through different mechanisms: i) direct interaction between GR and
transcription factors such as AP-1 and NF-kB [11,36,37]; ii) Inhibition
of the signalling of mitogen-activated protein kinase pathways that
mediates the expression of inﬂammatory genes [38,39] and iii)
competition with co-activator complexes [40,41]. Similar to GR,
PPARγ ligands exert anti-inﬂammatory activities in macrophages by
competition for transcriptional co-activators, including NF-kappaB
[42] and/or by inhibition of IFNγ stimulated Janus kinase-STAT1
signalling pathway [43].
A growing body of evidence supports the notion that a mutual
inhibition between pro-inﬂammatory mediators (cytokines and early
transcription factors) and nuclear receptors exists. Thus, while Toll
like receptor 4 activation by LPS leads to a robust up-regulation of
steady-state mRNA of several transcription factors, such as AP-1, NF-
kB, STAT1 and STAT3, and cytokines, including TNFα, IL1β and IFNγ[44]; it also downregulates the expression of members of nuclear
receptor superfamily such as RXRα, PXR, FXR, LXR, PPARα, PPARγ,
PXR and CAR [44]. Similarly to LPS, IFNγ, a Th1 type cytokine
secreted by CD4+ and CD8+ T cells, NK cells and dendritic cells,
decreases the expression of PPARγ in adipocytes by blocking the
synthesis and increasing the degradation of this transcription
regulator [25,45].
In the present study we demonstrated a novel cross talk between
the bile acid sensor FXR and the IFNγ network. In fact, we observed
that while FXR exerts anti-inﬂammatory and immuno-regulatory
activities, treatment of macrophages with IFNγ results in a STAT1-
dependent repression of FXR mRNA and protein expression. This
conclusion is based on the following results: i) FXR activation caused a
robust down-regulation of the expression of several IFNγ regulated
genes, including IRF1, IP10, MCP1 and ICAM1; ii) FXR gene expression
is down-regulated following treatment of macrophages with IFNγ; iii)
IFNγmediated repression of FXR is mediated by STAT1 activation. Our
ﬁndings suggest that the IFNγ induced repression of FXR mRNA is due
to a direct interaction of STAT1 with the FXR genomic. Thus we found
that the region between the second and the third exon of the FXR gene
contains three putative GAS/ISRE like elements that function as STAT1
binding sites (consensus GAS sequence: TTTCNNNNAAA) [25].
Transfection of macrophages with a vector expressing these three
GAS/IRE elements resulted in a robust inhibition of FXR transcription
in response to IFNγ treatment. The interaction of STAT1 on GAS/ISRE
elements on the FXR gene was further investigated by ChIP
experiments carried out with anti-STAT1 and anti-phospho-STAT1
antibodies in THP1 cells exposed to INFγ. The results of these
experiments conﬁrmed that the region between the second and
third exon of FXR genomic effectively binds STAT1. The speciﬁcity of
these STAT1 binding sites was further investigated by the following
experiments: i) EMSA assay showed that only the second STAT1
binding site (TTTCTAATAAA) was capable of binding STAT1 to the FXR
genomic following IFNγ stimulation and that this interaction resulted
in a repression of FXR transcription; ii) luciferase assay showed that
mutation of STAT1 response element P2 failed to reduce the
transactivation in presence of IFNγ.
Hence, the tightly controlled regulation of FXR gene expression
we observed in presence of IFNγ is due to the interaction of STAT1
to GAS element found in the region of FXR genomic between
second and third exon. Because FXR functions as a counter-
regulatory gene, and mice lacking FXR demonstrate a pro-
inﬂammatory phenotype [46], it is not surprising that FXR gene
expression is negatively regulated during inﬂammation [21]. Several
studies have shown that LPS, TNFα and IL1β exert a negative
regulatory role on FXR, and that FXR gene expression is down-
regulated in the liver during the acute phase of inﬂammation [21].
Although this negative modulation is of critical importance in the
context of regulation of early phase response, little is known
regarding the modulation of FXR in response to mediators located
at the interface between innate and immune response. In the
current study we have described for the ﬁrst time the molecular
mechanism of the IFNγ mediated repression of nuclear receptor
FXR. In conclusion, we have shown that FXR and IFNγ exert a
mutual regulatory effects and that FXR is regulated in response to
IFNγ activation in macrophages. This study highlights the potential
co-regulatory effect that mediators of inﬂammation exerts on genes
involved in bile acid homeostasis.
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